Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Depression Heterogeneity and Its Biological Underpinnings: Toward Immunometabolic Depression
Yuri Milaneschi, Femke Lamers, Michael Berk, et al.
Biological Psychiatry (2020) Vol. 88, Iss. 5, pp. 369-380
Closed Access | Times Cited: 296

Showing 1-25 of 296 citing articles:

Major depressive disorder: hypothesis, mechanism, prevention and treatment
Lulu Cui, Shu Li, Siman Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 219
Major depressive disorder
Wolfgang Marx, Brenda W.J.H. Penninx, Marco Solmi, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Closed Access | Times Cited: 216
Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms
Nils Kappelmann, Janine Arloth, Marios K. Georgakis, et al.
JAMA Psychiatry (2020) Vol. 78, Iss. 2, pp. 161-161
Open Access | Times Cited: 214
Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts
Yuri Milaneschi, Nils Kappelmann, Zheng Ye, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 12, pp. 7393-7402
Open Access | Times Cited: 205
Immune targets for therapeutic development in depression: towards precision medicine
Wayne C. Drevets, Gayle Wittenberg, Edward T. Bullmore, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 224-244
Open Access | Times Cited: 197
Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability
Marco Solmi, Manu Sharma, Emanuele F. Osimo, et al.
Brain Behavior and Immunity (2021) Vol. 97, pp. 193-203
Open Access | Times Cited: 123
Peripheral and central kynurenine pathway abnormalities in major depression
Elisabeth Paul, Lilly Schwieler, Sophie Erhardt, et al.
Brain Behavior and Immunity (2022) Vol. 101, pp. 136-145
Open Access | Times Cited: 79
Obesity and psychological distress
Andrew Steptoe, Philipp Frank
Philosophical Transactions of the Royal Society B Biological Sciences (2023) Vol. 378, Iss. 1888
Open Access | Times Cited: 54
Antidepressants or running therapy: Comparing effects on mental and physical health in patients with depression and anxiety disorders
Josine E. Verhoeven, Laura K. M. Han, Bianca A. Lever-van Milligen, et al.
Journal of Affective Disorders (2023) Vol. 329, pp. 19-29
Open Access | Times Cited: 47
Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin
Myles Corrigan, Aoife M. O’Rourke, Barry Moran, et al.
Neuronal Signaling (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 47
Association Between Depression and Physical Conditions Requiring Hospitalization
Philipp Frank, G. David Batty, Jaana Pentti, et al.
JAMA Psychiatry (2023) Vol. 80, Iss. 7, pp. 690-690
Open Access | Times Cited: 41
Reviewing the genetics of heterogeneity in depression: operationalizations, manifestations and etiologies
Na Cai, Karmel W. Choi, Eiko I. Fried
Human Molecular Genetics (2020) Vol. 29, Iss. R1, pp. R10-R18
Open Access | Times Cited: 130
Depression profilers and immuno-metabolic dysregulation: Longitudinal results from the NESDA study
Femke Lamers, Yuri Milaneschi, Christiaan H. Vinkers, et al.
Brain Behavior and Immunity (2020) Vol. 88, pp. 174-183
Open Access | Times Cited: 111
Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches
Óscar Soto-Angona, Gerard Anmella, María José Valdés-Florido, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 93
Depression and Obesity: Analysis of Common Biomarkers
Walter Milano, Paola Ambrosio, Francesca Carizzone, et al.
Diseases (2020) Vol. 8, Iss. 2, pp. 23-23
Open Access | Times Cited: 76
The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders
Danielle N. Jones, Mary Ann Raghanti
Journal of Chemical Neuroanatomy (2021) Vol. 114, pp. 101957-101957
Open Access | Times Cited: 71
Dysconnectivity of a brain functional network was associated with blood inflammatory markers in depression
Athina R. Aruldass, Manfred G. Kitzbichler, Sarah E. Morgan, et al.
Brain Behavior and Immunity (2021) Vol. 98, pp. 299-309
Open Access | Times Cited: 71
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression
Maria S. Simon, Carmen Schiweck, Gara Arteaga-Henríquez, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 111, pp. 110391-110391
Open Access | Times Cited: 70
Depression and inflammation: Correlation between changes in inflammatory markers with antidepressant response and long-term prognosis
Joakim Kofod, Betina Elfving, Elisabeth Handberg Nielsen, et al.
European Neuropsychopharmacology (2021) Vol. 54, pp. 116-125
Open Access | Times Cited: 69
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
Michael J. Lucido, Mandakh Bekhbat, David R. Goldsmith, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 1084-1117
Open Access | Times Cited: 65
Cohort profile of the longitudinal Netherlands Study of Depression and Anxiety (NESDA) on etiology, course and consequences of depressive and anxiety disorders
Brenda W.J.H. Penninx, Merijn Eikelenboom, Erik J. Giltay, et al.
Journal of Affective Disorders (2021) Vol. 287, pp. 69-77
Open Access | Times Cited: 62
Metabolomic and inflammatory signatures of symptom dimensions in major depression
Christopher R. Brydges, Sudeepa Bhattacharyya, Siamak Mahmoudian Dehkordi, et al.
Brain Behavior and Immunity (2022) Vol. 102, pp. 42-52
Open Access | Times Cited: 62
The association between plasma tryptophan catabolites and depression: The role of symptom profiles and inflammation
Yuri Milaneschi, Kelly A. Allers, Aartjan T.F. Beekman, et al.
Brain Behavior and Immunity (2021) Vol. 97, pp. 167-175
Open Access | Times Cited: 59
Inflammation and depression in young people: a systematic review and proposed inflammatory pathways
Yara J. Toenders, Liliana Laskaris, Christopher G. Davey, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 315-327
Open Access | Times Cited: 59
Overweight, obesity, and individual symptoms of depression: A multicohort study with replication in UK Biobank
Philipp Frank, Markus Jokela, G. David Batty, et al.
Brain Behavior and Immunity (2022) Vol. 105, pp. 192-200
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top